Cancer burden in the Jinchang cohort.

Yana Bai; Hongmei QU; Hongquan PU; Min Dai; Ning Cheng; Haiyan LI; Sheng Chang; Juansheng LI; Feng Kang; Xiaobin HU; Xiaowei Ren; Jie HE

Return

Cancer burden in the Jinchang cohort.

Author: Yana BAI ¹ ; Hongmei QU ² ; Hongquan PU ³ ; Min DAI ⁴ ; Ning CHENG ⁵ ; Haiyan LI ³ ; Sheng CHANG ⁶ ; Juansheng LI ¹ ; Feng KANG ³ ; Xiaobin HU ¹ ; Xiaowei REN ¹ ; Jie HE ⁴
Author Information

1. Institute of Epidemiology and Biostatistics, School of Public Health, Center for Cancer Prevention and Control, Lanzhou University, Lanzhou 730000, China.
2. Preventive Medicine Teaching and Research Section, Medical College, Northwest University for Nationalities, Lanzhou 730000, China.
3. Workers'Hospital of Jinchuan Group Company Limited, Jinchang 737100, China.
4. Program Office for Cancer Screening in Urban China, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
5. School of Basic Medical Sciences, Center for Cancer Prevention and Control, Lanzhou University, Lanzhou 730000, China.
6. Department of Cancer Prevention, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China.
Publication Type:Journal Article
MeSH: Breast Neoplasms; economics; mortality; China; epidemiology; Cohort Studies; Colorectal Neoplasms; economics; mortality; Cost of Illness; Esophageal Neoplasms; economics; mortality; Female; Hospitalization; economics; Humans; Liver Neoplasms; economics; mortality; Lung Neoplasms; economics; mortality; Male; Neoplasms; economics; mortality; Stomach Neoplasms; economics; mortality
From:Chinese Journal of Epidemiology 2016;37(3):306-310
CountryChina
Language:Chinese
Abstract:
OBJECTIVETo understand the disease burden caused by cancers in Jinchang cohort, and develop effective strategies for cancer prevention and control in this population.
METHODSThe cancer mortality data from 2001 to 2013 and the medical records for cancer patients from 2001 to 2010 in Jinchang cohort were collected. The disease burden caused by cancer was analyzed by using mortality rate, potential years of life lost (PYLL), working PYLL (WPYLL), and direct economic burden.
RESULTSDuring 2001-2013, in Jinchang cohort, the five leading cancers ranked by mortality rate were lung cancer (78.06/100,000), gastric cancer (38.03/100,000), liver cancer (37.23/100,000), esophageal cancer (19.06/100,000), and colorectal cancer (9.53/100,000). The five leading cancers in terms of PYLL (person-years) and WPYLL (person-years) were lung cancer (3480.33, 1161.00), liver cancer (2809.03, 1475.00), gastric cancer (2120.54, 844.00), esophageal cancer (949.61, 315.00), and colorectal cancer (539.90, 246.00). From 2001 to 2010, the five leading cancers in term of average daily cost of hospitalization were gastric cancer (8,102.23 Yuan), esophageal cancer (7135.79 Yuan), colorectal cancer (7064.38 Yuan), breast cancer (6723.53 Yuan), and lung cancer (6309.39 Yuan).
CONCLUSIONSThe cancers common causing higher disease burden in Jinchang cohort were lung cancer, gastric cancer, liver cancer, esophageal cancer and colorectal cancer. The lung cancer disease burden was the highest.